Skip to content

Annogen B.V.

Annogen B.V.

At Annogen, we use our SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression. Also, we establish databases in which we functionally annotate millions of non-coding sequence variants for their effect on promoter and enhancer activity. This enables researchers to qualitatively interpret non-coding sequence variants in humans, animals and plants in the way we already can for coding sequence variants.

 

Expertise:

  • Promoter screens for gene and cell therapy, including inducible promoters
  • Functional annotation of non-coding sequence variants
  • Synthetic biology
  • Saturating mutagenesis screens
  • SafeHarbor screens for the identification of favorable genomic integrations sites
Logo Annogen logo_higherres
Contactpersoon
Joris van Arensbergen, PhD
Adres
Science Park 406, 1098 XH Amsterdam
Telefoonnummer

At Annogen, we use our SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression. Also, we establish databases in which we functionally annotate millions of non-coding sequence variants for their effect on promoter and enhancer activity. This enables researchers to qualitatively interpret non-coding sequence variants in humans, animals and plants in the way we already can for coding sequence variants.

 

Expertise:

  • Promoter screens for gene and cell therapy, including inducible promoters
  • Functional annotation of non-coding sequence variants
  • Synthetic biology
  • Saturating mutagenesis screens
  • SafeHarbor screens for the identification of favorable genomic integrations sites
Contactpersoon
Joris van Arensbergen, PhD
Adres
Science Park 406, 1098 XH Amsterdam